Olema Oncology ^Companies

Olema Oncology is a preclinical biotechnology company that focuses on developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. Their main goal is to transform the standard of care for women living with cancer by developing more convenient and effective therapies. They leverage their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance to design compounds that are superior to current drugs and those in development. Olema Oncology aims to improve outcomes for women living with cancer by developing innovative therapies. For more information, please visit their website.